UbiHub specifications

Information


Unique identifier OMICS_33787
Name UbiHub
Restrictions to use None
Community driven No
Data access Browse
User data submission Not allowed
Maintained Yes

Maintainer


  • person_outline Matthieu Schapira

Publication for UbiHub

UbiHub institution(s)
Structural Genomics Consortium, University of Toronto, Toronto, ON, Canada; Structural Genomics Consortium, University of Oxford, Oxford, UK; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada; Department of Chemistry and Biochemistry, University of Windsor, Windsor, ON, Canada; Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK
UbiHub funding source(s)
Supported by AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and The Wellcome [106169/ZZ14/Z].

UbiHub reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review UbiHub